Stockscreener 앱 받기
123.25
0.41%
0.50
시간 외 거래:
123.25
Aptargroup Inc 주식(ATR)의 최신 뉴스
Trends in Caps and Closures Market 2025-35 - GlobeNewswire Inc.
AptarGroup, Inc. (NYSE:ATR) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance
Will AptarGroup Inc. stock gain from strong economyJuly 2025 Patterns & Weekly Consistent Profit Watchlists - Улправда
Is AptarGroup Inc. stock trading at a premium valuationProfit Target & Fast Momentum Stock Entry Tips - Улправда
Will AptarGroup Inc. stock rally after Fed decisionsWeekly Gains Summary & Smart Swing Trading Alerts - Улправда
AptarGroup Completes $600M Senior Notes Offering - MSN
Why AptarGroup Inc. stock is in analyst buy zoneWeekly Stock Analysis & Consistent Return Investment Signals - DonanımHaber
Is AptarGroup Inc. stock trading near support levelsJuly 2025 PreEarnings & Weekly Top Stock Performers List - DonanımHaber
Is AptarGroup Inc. (AGT) stock among top earnings playsEarnings Recap Summary & Daily Technical Stock Forecast Reports - DonanımHaber
Targets Report: Will AptarGroup Inc. stock see insider buying2025 Geopolitical Influence & Fast Momentum Entry Tips - DonanımHaber
Can AptarGroup Inc. stock rebound after recent weaknessWeekly Investment Recap & Accurate Buy Signal Alerts - DonanımHaber
Is AptarGroup Inc. stock vulnerable to regulatory risksJuly 2025 Setups & Verified Trade Idea Suggestions - DonanımHaber
Will AptarGroup Inc. stock outperform growth indexesJuly 2025 Spike Watch & AI Driven Price Forecasts - Улправда
AptarGroup (STU:AGT) EV-to-OCF : 15.23 (As of Dec. 19, 2025) - GuruFocus
How AptarGroup Inc. stock benefits from global expansionJuly 2025 Outlook & AI Powered Market Trend Analysis - Улправда
Why AptarGroup Inc. stock is a must watch tickerMarket Volume Report & Smart Allocation Stock Tips - Улправда
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FD - PharmiWeb.com
Aptar’s nasal spray system to deliver newly approved PSVT treatment By Investing.com - Investing.com Nigeria
Aptar’s nasal spray system to deliver newly approved PSVT treatment - Investing.com
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Eagle-Tribune
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) – Company AnnouncementFT.com - Financial Times
Self-administered nasal spray offers new option for sudden PSVT episodes - Stock Titan
AptarGroup Insider Sold Shares Worth $1,818,435, According to a Recent SEC Filing - marketscreener.com
Insider Sell: Daniel Ackerman Sells 15,000 Shares of AptarGroup Inc (ATR) - GuruFocus
APTARGROUP's Chief Accounting Officer Sells 15,000 Shares - TradingView — Track All Markets
Officer Ackerman Sells 15,000 ($1.8M) Of AptarGroup Inc [ATR] - TradingView — Track All Markets
What analysts say about AptarGroup Inc stockFundamental Stock Analysis & Calculate Profit Targets With AI Accuracy - earlytimes.in
Officer Ackerman Files To Sell 15,000 Of AptarGroup Inc [ATR] - TradingView — Track All Markets
ATR (ATR) Form 144 shows planned sale of 15,000 common shares - Stock Titan
Did AptarGroup’s (ATR) Legal and Inventory Strains Just Challenge Its Innovation-Led Premium Narrative? - Sahm
General Motors and AptarGroup have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Bear of the Day: AptarGroup (ATR) - Finviz
AptarGroup Inc. (ATR) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Is AptarGroup (NYSE:ATR) Using Too Much Debt? - 富途牛牛
AptarGroup Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Has AptarGroup’s Share Price Slide Created a New Opportunity in 2025? - Yahoo Finance
AptarGroup (ATR): Revisiting Valuation After Mixed 2024 Performance and Recent Share Price Rebound - Yahoo Finance
Is the Options Market Predicting a Spike in AptarGroup Stock? - MSN
How AptarGroup Inc. stock compares with market leaders2025 Growth vs Value & Fast Exit Strategy with Risk Control - Newser
Aptar Named One of America's Most Responsible Companies by Newsw - GuruFocus
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year - Enidnews.com
Will AptarGroup Inc. (AGT) stock benefit from mergersQuarterly Investment Review & High Conviction Investment Ideas - Newser
Norges Bank Makes New $118.18 Million Investment in AptarGroup, Inc. $ATR - MarketBeat
Edgestream Partners L.P. Invests $3.40 Million in AptarGroup, Inc. $ATR - MarketBeat
How AptarGroup Inc. (AGT) stock reacts to new regulationsVolume Spike & Daily Growth Stock Tips - Newser
What analyst consensus says on AptarGroup Inc. stockJuly 2025 EndofMonth & Real-Time Market Sentiment Alerts - Newser
Will AptarGroup Inc. stock see valuation expansion2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
AptarGroup’s Latest Acquisition Is Turning Heads — The Sommaplast Synergy Explained! - Smartkarma
Panagora Asset Management Inc. Cuts Holdings in AptarGroup, Inc. $ATR - MarketBeat
Lido Advisors LLC Grows Stock Holdings in AptarGroup, Inc. $ATR - MarketBeat
AptarGroup, Inc. $ATR Stake Cut by Mackenzie Financial Corp - MarketBeat
Will AptarGroup Inc. stock beat revenue estimatesPortfolio Update Summary & Weekly High Return Stock Opportunities - Newser
Can AptarGroup Inc. (AGT) stock sustain breakout momentumTrade Volume Report & Risk Controlled Daily Trade Plans - Newser
Will AptarGroup Inc. (AGT) stock outperform foreign stocksPortfolio Gains Report & Stock Timing and Entry Methods - Newser
0.34%
0.85%
자본화:
|
볼륨(24시간):